Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

ProPhase Labs Q3 EPS $(0.16) Misses $(0.11) Estimate, Sales $883.000K Miss $5.690M Estimate

Author: Benzinga Newsdesk | November 19, 2025 08:16am
ProPhase Labs (NASDAQ:PRPH) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of $(0.11) by 45.45 percent. This is a 54.29 percent increase over losses of $(0.35) per share from the same period last year. The company reported quarterly sales of $883.000 thousand which missed the analyst consensus estimate of $5.690 million by 84.48 percent. This is a 37.64 percent decrease over sales of $1.416 million the same period last year.

Posted In: PRPH


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist